Cargando…

KDELR2 knockdown synergizes with temozolomide to induce glioma cell apoptosis through the CHOP and JNK/p38 pathways

BACKGROUND: The C-terminal tetrapeptide Lys-Asp-Glu-Leu receptors (KDELRs) are transmembrane proteins that regulate ER stress (ERS) response, growth, differentiation, and immune responses. There is an association between KDELR2and promotion of glioblastoma tumorigenesis. The aim of the present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guofeng, Wang, Bin, Cheng, Shiqi, Fan, Hengyi, Liu, Shaowen, Zhou, Bin, Liu, Weibin, Liang, Rui, Tang, Youjia, Zhang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799170/ https://www.ncbi.nlm.nih.gov/pubmed/35116653 http://dx.doi.org/10.21037/tcr-21-869

Ejemplares similares

Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells
por: Ma, Jian, et al.
Publicado: (2016)

KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma
por: Yuan, Yifan, et al.
Publicado: (2022)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
por: Jiang, Pengfei, et al.
Publicado: (2016)

KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression
por: Wei, Haoran, et al.
Publicado: (2021)

KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma
por: Zhang, Jingnan, et al.
Publicado: (2022)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation
por: Ruggiero, Carmen, et al.
Publicado: (2014)

IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
por: Bajaj, Rakhee, et al.
Publicado: (2020)

KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration
por: Ma, Sai, et al.
Publicado: (2023)

Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide
por: Maurer, Gabriele D., et al.
Publicado: (2019)

Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation
por: Chen, Hongwu, et al.
Publicado: (2019)

Transcriptomics of a KDELR1 knockout cell line reveals modulated cell adhesion properties
por: Blum, Andrea, et al.
Publicado: (2019)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021)

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020)

METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability
por: Shi, Jia, et al.
Publicado: (2023)

Polyphyllin VI Induces Apoptosis and Autophagy via Reactive Oxygen Species Mediated JNK and P38 Activation in Glioma
por: Liu, Wei, et al.
Publicado: (2020)

Knockdown of hsa_circ_0008922 inhibits the progression of glioma
por: Xue, Chunhong, et al.
Publicado: (2022)

Two novel bi‐allelic KDELR2 missense variants cause osteogenesis imperfecta with neurodevelopmental features
por: Efthymiou, Stephanie, et al.
Publicado: (2021)

KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion
por: Meng, Xiangui, et al.
Publicado: (2022)

Tetramethylpyrazine Inhibits the Proliferation and Invasion of Glioma Cells by Regulating the UBL7-AS1/miR-144-3p Pathway
por: Liang, Rui, et al.
Publicado: (2022)

ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide
por: Chen, Xueru, et al.
Publicado: (2021)

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
por: Cao, Yingxiao, et al.
Publicado: (2020)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells In Vitro by Inhibiting Autophagy
por: Chen, Zhihua, et al.
Publicado: (2022)

Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
por: Chen, Lei, et al.
Publicado: (2019)

Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021)

A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation
por: Liu, Xin, et al.
Publicado: (2016)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
por: Hu, Zhifang, et al.
Publicado: (2020)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

KDELR2 Competes with Measles Virus Envelope Proteins for Cellular Chaperones Reducing Their Chaperone-Mediated Cell Surface Transport
por: Tiwarekar, Vishakha, et al.
Publicado: (2019)

E96V Mutation in the Kdelr3 Gene Is Associated with Type 2 Diabetes Susceptibility in Obese NZO Mice
por: Altenhofen, Delsi, et al.
Publicado: (2023)

Rubidium Chloride Targets Jnk/p38-Mediated NF-κB Activation to Attenuate Osteoclastogenesis and Facilitate Osteoblastogenesis
por: Ouyang, Zhengxiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pcppik79n7esu59hcnrmqrbv63